微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Profound Medical (NASDAQ:PROF) +29%
STAAR Surgical (NASDAQ:STAA) +20%
AdaptHealth (NASDAQ:AHCO) +15%
Flora Growth (NASDAQ:FLGC) +12%
Invacare (NYSE:IVC) +14%
L...查看全文
郁闷的鞋套-2021-07-20 12:42
$Nevro(NVRO)$ 2021年7月19日,Nevro公司宣布,其专有的10 kHZ脊髓刺激(SCS)“Senza”系统,已获得美国FDA批准,用于治疗疼痛性糖尿病神经病变(PDN)引起的慢性疼痛。新闻稿指出,这是FDA批准的首款以PDN为适应症的脊髓刺激系统。该公司将根据本次批准,推出的名为“HFX”的PDN治疗相关产品。HF...查看全文
智通财经APP获悉,鉴于多数大型医疗科技公司已公开表示有意在该领域进行收购,摩根大通分析师Robbie Marcus列出了潜在的收购目标,包括:英特格拉生命科学(IART.US)、Nevro (NVRO.US)、纽瓦索器材(NUVA.US)、Silk Road Medical (SILK.US... 网页链接
$Nevro(NVRO)$ 内部交易: 2015-11-18,Director,JAEGER WILFRED E ,卖出,126632普通股, $52.35
$Nevro(NVRO)$ 内部交易: 2015-11-17,Director,JAEGER WILFRED E ,卖出,48368普通股, $51.94
$Nevro(NVRO)$ 8-K - Current report Filed: 2015-11-09 AccNo: 0001193125-15-371948 Size: 86 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Nevro(NVRO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2015-11-09 AccNo: 0001193125-15-372084 Size: 3 MB 网页链接
$Nevro(NVRO)$ 美东时间 2015-11-09 16:30 Q3 2015 Nevro Corp Earnings Call 网页链接
$Nevro(NVRO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2015-09-14 AccNo: 0001193125-15-319408 Size: 38 KB 网页链接
$Nevro(NVRO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2015-09-24 AccNo: 0000919574-15-007041 Size: 126 KB 网页链接
$Nevro(NVRO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2015-08-27 AccNo: 0000919574-15-006551 Size: 169 KB 网页链接
$Nevro(NVRO)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2015-10-09 AccNo: 0000315066-15-003168 Size: 9 KB 网页链接
$Nevro(NVRO)$ EFFECT - Notice of Effectiveness Filed: 2015-06-02 AccNo: 9999999995-15-001505 Size: 1 KB 网页链接